Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 175Leukemia 147Myelodysplastic Syndromes 138Precursor Cell Lymphoblastic Leukemia-Lymphoma 112Lymphoma 99Lymphoma, Non-Hodgkin 86Multiple Myeloma 81Hodgkin Disease 74Leukemia, Lymphocytic, Chronic, B-Cell 69Congenital Abnormalities 62Leukemia, Myeloid, Chronic-Phase 60Myeloproliferative Disorders 57Lymphoma, Large B-Cell, Diffuse 56Neoplasms, Plasma Cell 53Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 52Lymphoma, Follicular 51Lymphoma, Mantle-Cell 47Burkitt Lymphoma 46Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Lymphoma, B-Cell, Marginal Zone 44Lymphoma, Large-Cell, Immunoblastic 43Blast Crisis 43Anemia, Refractory, with Excess of Blasts 43Primary Myelofibrosis 40Recurrence 36Hematologic Neoplasms 35Graft vs Host Disease 35Myelodysplastic-Myeloproliferative Diseases 34Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32

Interventions

fludarabine phosphate 2fludarabine 2Busulfan 2AP 1903 reagent 2Thiotepa 1Tacrolimus 1Photopheresis 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Cyclosporins 1Cyclophosphamide 1Clofarabine 1Clinical Trials, Phase I as Topic 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hemoglobinopathies × Busulfan × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡